Drosten, Christian Panning, Marcus Drexler, Jan Felix Hänsel, Florian Pedroso, Celia Yeats, Jane Samuel, Matthew Liedigk, Britta Lippert, Ute Stürmer, Martin Doerr, Hans Wilhelm Brites, Carlos Preiser, Wolfgang De Souza Luna, Luciano Kleber
(American Association for Clinical Chemistry, 2006-04)
BACKGROUND: Current HIV-1 viral-load assays are too expensive for resource-limited settings. In some countries, monitoring of antiretroviral therapy is now more expensive than treatment itself. In addition, some commercial ...